The Annals Visit the NEW pharmaCE.com
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 35, No. 6, pp. 755-764. DOI 10.1345/aph.10216
© 2001 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, J.
Right arrow Articles by Balwin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, J.
Right arrow Articles by Balwin, S.

Research Articles

L-arginine in the management of cardiovascular diseases

JW Cheng, SN Baldwin, and SN Balwin

OBJECTIVE: To examine the role of L-arginine in the management of cardiovascular diseases. DATA SOURCES: A MEDLINE search (1966-April 2000) of review articles, using the search terms arginine, nitric oxide, and cardiovascular diseases, was conducted. After reviewing these articles, primary studies using the search terms arginine, hypercholesterolemia, hypertension, diabetes, smoking, ischemic heart disease, and heart failure were reviewed. STUDY SELECTION: English-language human studies were selected and evaluated based on quality of review. DATA SYNTHESIS: Small-scale studies have demonstrated that intravenous L-arginine augments endothelial function by enhancing vasodilation and reducing monocyte adhesion. Oral supplementation demonstrated similar effects as well as improvement of exercise ability in patients with cardiovascular diseases. CONCLUSIONS: L-arginine improves the management of multiple cardiovascular diseases. However, most published human studies are small. Before therapy can be routinely recommended, larger, well-designed studies are required to confirm its effect.


This article has been cited by other articles:


Home page
 JAMAHome page
S. P. Schulman, L. C. Becker, D. A. Kass, H. C. Champion, M. L. Terrin, S. Forman, K. V. Ernst, M. D. Kelemen, S. N. Townsend, A. Capriotti, et al.
L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial
JAMA, January 4, 2006; 295(1): 58 - 64.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. K. McConell, N. N. Huynh, R. S. Lee-Young, B. J. Canny, and G. D. Wadley
L-Arginine infusion increases glucose clearance during prolonged exercise in humans
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E60 - E66.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. G. Herman and S. Moncada
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
Eur. Heart J., October 1, 2005; 26(19): 1945 - 1955.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. G Ferrini, H. H Davila, E. G.A Valente, N. F Gonzalez-Cadavid, and J. Rajfer
Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media
Cardiovasc Res, March 1, 2004; 61(4): 796 - 805.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Schon, D. Elias, F. Moges, E. Melese, T. Tessema, O. Stendahl, S. Britton, and T. Sundqvist
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
Eur. Respir. J., March 1, 2003; 21(3): 483 - 488.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2001 by Harvey Whitney Books Company.